A prescription cream and an ointment that millions of
Americans use to control eczema should carry strong
warnings to alert consumers that the drugs may
increase the risk of some forms of cancer, especially
among children, a federal panel concluded. Although
the risks posed by Elidel and Protopic remain far
from clear, the Food and Drug Administration advisory
panel said the agency should take steps to
aggressively caution consumers and monitor the drugs'
safety, including adding a prominent "black box" to
the labels.
http://www.washingtonpost.com/ac2/wp-dyn/A26939-2005Feb15?language=printer
